Shaanxi Buchang High-Tech Pharmaceutical

Shaanxi Buchang High-Tech Pharmaceutical is a core subsidiary of Shandong Buchang Pharmaceuticals, a leading Chinese pharmaceutical group specializing in Traditional Chinese Medicine (TCM) and modern pharmaceuticals. The company is renowned for its focus on cardiovascular and cerebrovascular health, with flagship products like Naoxintong Capsules and Danhong Injection. In recent years, the firm has aggressively expanded its portfolio into high-tech sectors, including biologics, vaccines, and small molecule innovative drugs. Buchang operates extensive manufacturing facilities and maintains a strong domestic market presence while pursuing international R&D collaborations. The company is a key player in the Chinese healthcare market, consistently ranking among the top domestic pharmaceutical firms by revenue and R&D investment. Its pipeline includes several biosimilars and novel biologics in late-stage clinical trials, targeting oncology and infectious diseases.